Atypical respiratory pathogens

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
R. Cavallo  Clinical Microbiology and Infection 
Characteristics of pathogenic Neisseria meningitidis in Moscow: prevalence of ‘non- European’ strains  Irina S. Koroleva, Alexander E. Platonov, Arie van.
Approach to diagnosis of infective endocarditis
Herpes zoster in non-hospitalized children
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
The microarray technology: facts and controversies
R. Cantón  Clinical Microbiology and Infection 
Hydatid disease Clinical Microbiology and Infection
Link between intracellular pathogens and cardiovascular diseases
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
F. Rodríguez-Gómez, O. Cuevas, J. Anguita, P. Muñoz 
Evaluation of viral co-infections in hospitalized and non-hospitalized children with respiratory infections using microarrays  S. Kouni, P. Karakitsos,
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species  Jacques Dubois, Claude St-Pierre  Clinical.
Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente  
Structure of grepafloxacin relative to activity and safety profile
Vector control: a cornerstone in the malaria elimination campaign
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Training for the infectious diseases speciality in Norway
F. Grill, P. Muñoz, R. Jofre, E. Bouza 
Pharmacodynamic properties of HMR 3004, a novel ketolide, on respiratory pathogens, enterococci and Bacteroides fragilis demonstrated by studies of time.
Cephalosporins: a pharmacological update
Epidemiology of opportunistic infections in AIDS patients
Laboratory diagnosis and biosafety issues of biological warfare agents
Comparative in vitro activity of ertapenem against bacterial pathogens isolated from patients with lower respiratory tract infections  P.S. Hicks, B.
Sepsis and neutropenia induced by clozapine
Gastrointestinal and respiratory Mycobacterium avium colonization and development of disseminated infection in HIV-positive patients  Giampietro Nardi,
Uncommon opportunistic fungi: new nosocomial threats
Levofloxacin in the treatment of ventilator-associated pneumonia
Metagenomics and probiotics
Effect of antioxidants on the immune response of Helicobacter pylori
Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin  King A. , Bathgate.
Laboratory diagnosis of Clostridium difficile disease
S8 – S47 and O50 – O440 Clinical Microbiology and Infection
Interactions between cytomegalovirus and the p53 tumor suppressor gene in atherosclerotic vascular disease  Inge O. Baas, G. Johan A. Offerhaus, Ralph.
G.R. Davies  Clinical Microbiology and Infection 
A. Bryskier  Clinical Microbiology and Infection 
Community-acquired pneumonia: epidemiologic and clinical consideration
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Training in infectious diseases and tropical medicine in Britain
Clinical infection services—the Leiden experience
Ethan Rubinstein, Itzhak Levy  Clinical Microbiology and Infection 
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
European guidelines for diagnosis and management of patients with suspected herpes simplex encephalitis  Miles Denton, Kevin G Kerr, Fraser Lewis  Clinical.
Clinical Microbiology and Infection
Detection of IgA and low-avidity IgG antibodies for the diagnosis of recent active toxoplasmosis  José Gutiérrez, María Rodríguez, Gonzalo Piédrola, María.
Overview of cefixime use in community-acquired infections
A. Norberg, C.E. Nord, B. Evengård  Clinical Microbiology and Infection 
Brita Bruun, Henrik Westh, Jørgen Stenderup 
The atypical pneumonias: clinical diagnosis and importance
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Virology: a scientific discipline facing new challenges
New oral cephalosporins in pediatric community-acquired infections
D.L. Monnet, T.L. Sørensen  Clinical Microbiology and Infection 
Three years experience of real-time PCR for the diagnosis of Q fever
New patterns of HIV-1 resistance during HAART
J.A. Pérez-Molina, F. Fernández  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
Localized Mycobacterium avium complex infection in a patient on HAART
The future of diagnostic bacteriology
Vincent Calvez, Marc Grandadam  Clinical Microbiology and Infection 
Presentation transcript:

Atypical respiratory pathogens Pekka Saikku  Clinical Microbiology and Infection  Volume 3, Issue 6, Pages 599-604 (December 1997) DOI: 10.1111/j.1469-0691.1997.tb00464.x Copyright © 1997 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Geometric mean titers (GMTs) in relation to age in patients with suspected viral illnesses studied at the Department of Virology, University of Helsinki. M.pn, Mycoplasma pneumoniae (58 000 samples studied); C.pn, Chlamydia pneumoniae (20 000 samples studied). Clinical Microbiology and Infection 1997 3, 599-604DOI: (10.1111/j.1469-0691.1997.tb00464.x) Copyright © 1997 European Society of Clinical Infectious Diseases Terms and Conditions